In Utero Exposure to Antihypertensive Medication During Pregnancy and Neonatal and Child Health Outcomes
ABSTRACT Background Although pharmacotherapy is to be avoided wherever possible during pregnancy, aggressive pharmacotherapy is required for the treatment of pregnancy associated hypertension, which remains a leading cause of morbidity and mortality in the UK. While the teratogenic effects of angio...
Main Authors: | Catherine Fitton, Markus Steiner, Lorna Aucott, Jill Pell, Michael Fleming, James McLay |
---|---|
Format: | Article |
Language: | English |
Published: |
Swansea University
2017-04-01
|
Series: | International Journal of Population Data Science |
Online Access: | https://ijpds.org/article/view/239 |
Similar Items
-
Education and health outcomes of children treated for chronic conditions
by: Michael Fleming, et al.
Published: (2019-11-01) -
Investigating the relationships between chronic ill health and educational outcomes in children
by: Michael Fleming, et al.
Published: (2017-04-01) -
Reversible Neonatal Cholestasis Following In Utero Exposure to Valproic Acid
by: Douglas G Chang, et al.
Published: (2020-12-01) -
Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
by: Kristen M Gawronski, et al.
Published: (2014-04-01) -
Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth.
by: Andrea V Margulis, et al.
Published: (2019-01-01)